CTNNB1 and melanoma: The median OS of patients with APC/CTNNB1-mutant melanomas trended to be significantly shorter compared to melanomas without APC/CTNNB1 mutations (29 vs. 36.3 months, log-rank HR 1.57, 95CI 0.92–2.69, p = 0.099).